Rosenstock J, Emral R, Sauque-Reyna L, Mohan V, et al. Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial. Diabetes Care 2021 Jun 28. pii: dc21-0393. doi: 10.2337/dc21-0393.
PMID: 34183429